POTENTIAL SPIN-OUT

Public Ventures

CO-FOUNDED: 1997

We provide a platform where the best, most promising venture & growth stage companies can raise money publicly through our unique and passionate members-only community of investors

Our wholly owned subsidiary, MDB Capital, licensed under the name MDB Capital Group LLC, a registered broker-dealer (CRD#: 42677/SEC#:8-49951) is the backbone of our community-oriented financing. We are expanding its capabilities to act as a licensed clearing firm and changing the name to Public Ventures.

Our wholly owned subsidiary, Public Ventures, is the backbone of our community-oriented financing. Public Ventures’ strategy will be to foster a market where venture stage businesses are supported and financed by a community of likeminded investors and entrepreneurs experienced in the development of successful companies. We envision fostering a close-knit community of longterm public venture investors “Members” through which they may submit investment opportunities and become involved with nascent and developing companies. Their involvement may include suggesting start-up and developing companies as potential investments, making investments in these and other targeted companies, and consulting with our invested companies to help them grow into tomorrow’s leaders.

Up next – Cue Biopharma

PatentVest Logo

Selectively modulating T-cells to fight cancer

Cue Biopharma (NASDAQ: CUE), a clinical stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T-cells directly within the body to transform the treatment of cancer, infectious diseases, and autoimmune diseases.